Skip to main content
. 2018 Apr 18;8:81. doi: 10.1038/s41398-018-0126-6

Fig. 1. Baseline Normalized Expression Levels of GSK3β, CRMP1, AKT1 and PKCein Patients with Bipolar Disorder Compared to Controls.

Fig. 1

Normalized expression levels of GSK3β, CRMP1, AKT1 and PKCein bipolar subjects compared to controls. GAPDH was used for an internal control for normalization of expression levels of these candidate genes. Significant differences (P < 0.02) were observed in the expression levels of GSK3β and CRMP1 in symptomatic bipolar subjects compared to controls